Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dopa-sensitive dystonia].

P Rondot1, J Aicardi, F Goutières

  • 1Hôpital Sainte Anne, Paris.

Revue Neurologique
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paroxysmal extreme pain disorder (previously familial rectal pain syndrome).

Neurology·2007
Same author

[Aicardi-Goutieres syndrome: an oft unrecognised familial early-onset encephalopathy].

Revue neurologique·2005
Same author

[The effect of refractory epileptic seizures on cognitive processes].

Revista de neurologia·2003
Same author

Hereditary infantile hemiparesis, retinal arteriolar tortuosity, and leukoencephalopathy.

Neurology·2003
Same author

Dreamy state: a case report from the selected writings of John Hughlings Jackson. Brain 1874.

Epileptic disorders : international epilepsy journal with videotape·2001
Same author

Late-onset mitochondrial DNA depletion: DNA copy number, multiple deletions, and compensation.

Annals of neurology·2001
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
Same journal

Novel variants and rare clinical presentations in MFN2-related Charcot-Marie-Tooth disease: Insights from 10 families.

Revue neurologique·2026
See all related articles

Dopa-sensitive dystonia, a rare neurological disorder, presents in early childhood and is effectively managed with levodopa. This condition, distinct from juvenile Parkinson's, shows consistent therapeutic response to dopaminergic treatment.

Area of Science:

  • Neurology
  • Genetics

Context:

  • Dopa-sensitive dystonia is a recognized neurological disorder with onset typically in early childhood.
  • The condition can lead to significant functional disability, initially affecting the lower limbs and potentially generalizing.

Purpose:

  • To present eight clinical cases of dopa-sensitive dystonia in children.
  • To discuss the clinical presentation, potential inheritance patterns, and diagnostic challenges.
  • To highlight the efficacy and long-term management of levodopa treatment.

Summary:

  • Eight cases (5 boys, 3 girls) of dopa-sensitive dystonia are detailed, suggesting possible recessive inheritance due to affected siblings.
  • Levodopa treatment provides remarkable and sustained results, requiring indefinite continuation, with dosage adjustments possible over time.

Related Experiment Videos

  • Distinct from juvenile Parkinson's disease, dopa-sensitive dystonia exhibits consistent therapeutic efficacy without fluctuations and is characterized by dopaminergic insufficiency.

    • Impact:

    • Levodopa offers a highly effective, long-term therapeutic strategy for managing dopa-sensitive dystonia.
    • Understanding this condition aids in differentiating it from other childhood-onset movement disorders.
    • Further research into biological markers could improve diagnostic accuracy.